Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
domperidone + rabeprazole
- Development stage
- Unknown
- Lead developer
- Fawn
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
CANALI (specifically CANALI 40 DSR Capsule) is a fixed-dose combination of rabeprazole sodium and domperidone. Rabeprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase pump in parietal cells. Domperidone is a dopamine D2 receptor antagonist with prokinetic and antiemetic properties that enhances gastrointestinal motility and accelerates gastric emptying. This combination is marketed by Fawn Incor and is indicated for the treatment of gastroesophageal reflux disease (GERD), dyspepsia, and other acid-related gastrointestinal disorders associated with motility dysfunction.
- Brand names
- CANALICANALI 40 DSRCANALI40 DSRCANALI-40 DSRCANALI 40 DSR CapsuleCANALI40 DSR CapsuleCANALI-40 DSR CapsuleCANALI D
- Other names
- domperidone + rabeprazolerabeprazole + domperidone
02
Targets
ATP4A (Potassium–transporting ATPase alpha chain 1)DRD2 (Dopamine D2 Receptor)
Beyond the preview
Go deeper on domperidone + rabeprazole.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on domperidone + rabeprazole.